The company’s first large-scale distribution platform to healthcare providers in the US. Two products. North America’s leading healthcare provider platform.
What the launch means
Fullscript is North America’s leading platform for healthcare providers. Sigrid is launching two products: SiPore® Capsules (a dietary supplement) and SiPore® Liquid (a food for special medical purposes, with the highest dose strength of the SiPore® technology). The launch creates a scalable commercial channel in the US for the company’s patented technology — according to CEO Claus Kjærsgaard, an important milestone in the commercial US strategy.
The launch follows the recent acceptance of the company’s pivotal SHINE study for publication in eClinicalMedicine, a peer-reviewed journal published by The Lancet Discovery Science group.
About SiPore®
Patented technology that acts locally in the gastrointestinal tract: it mechanically binds the enzymes that break down carbohydrates and fat, supporting a more even metabolic response after meals. Founded in 2014 by Professor Tore Bengtsson. Headquartered in Stockholm.
Source: Sigrid Therapeutics press release, 5 August 2026.
Sigrid Therapeutics is traded on Eqvor
